Sunmax Biotechnology Co., Ltd. (TPEX:4728)
Taiwan · Delayed Price · Currency is TWD 380.00
0.00 (0.00%)
May 29, 2026, 12:03 PM CST
Sunmax Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 724.03 | 725.75 | 679.41 | 625.71 | 533.83 | 245.64 |
Depreciation & Amortization | 107.33 | 102.31 | 99.21 | 72.83 | 58.15 | 55.76 |
Loss (Gain) From Sale of Assets | 0.43 | 0.43 | 0.49 | 0.13 | -0.46 | 2.1 |
Provision & Write-off of Bad Debts | - | - | - | - | -0.39 | 0.24 |
Other Operating Activities | -4.87 | 15.72 | -21.59 | 17.96 | 42.52 | 18.34 |
Change in Accounts Receivable | 0.46 | -0.34 | 0.47 | -0.23 | 3.34 | 1.81 |
Change in Inventory | -23.5 | 4.7 | -63.69 | -19.88 | -19.05 | -29.41 |
Change in Accounts Payable | 0.18 | -11.02 | 11.35 | -7.61 | 9.46 | 3.58 |
Change in Unearned Revenue | -17.33 | -51.8 | -128.72 | 142.48 | -62.86 | 11.01 |
Change in Other Net Operating Assets | 34.5 | 40.18 | -15.91 | 17.17 | 80.03 | -65.8 |
Operating Cash Flow | 821.23 | 825.92 | 561.04 | 848.56 | 644.57 | 243.28 |
Operating Cash Flow Growth | 21.63% | 47.21% | -33.88% | 31.65% | 164.95% | -37.13% |
Capital Expenditures | -87.01 | -59.61 | -31.97 | -107.66 | -154.58 | -253.02 |
Sale of Property, Plant & Equipment | - | - | - | 0.42 | 0.51 | 3.1 |
Cash Acquisitions | - | - | -7.2 | - | - | - |
Sale (Purchase) of Intangibles | -8.45 | -8.73 | -5.03 | -2.73 | -0.59 | -2.4 |
Sale (Purchase) of Real Estate | - | - | - | -0.96 | - | - |
Investment in Securities | -11 | -161 | 24.96 | 125 | -136.43 | 39.68 |
Other Investing Activities | -6.74 | -10.62 | -2.71 | -30.1 | -85.53 | -72.53 |
Investing Cash Flow | -113.2 | -239.96 | -21.94 | -16.04 | -376.62 | -285.17 |
Long-Term Debt Repaid | - | -30.08 | -29.65 | -22.97 | -39.16 | -24.39 |
Net Debt Issued (Repaid) | -30.74 | -30.08 | -29.65 | -22.97 | -39.16 | -24.39 |
Common Dividends Paid | -631.77 | -631.77 | -599.09 | -517.4 | -239.64 | -108.93 |
Other Financing Activities | 0.19 | -1.28 | 2.64 | -9.43 | -2.41 | 1.35 |
Financing Cash Flow | -662.33 | -663.13 | -626.11 | -549.8 | -281.21 | -131.97 |
Foreign Exchange Rate Adjustments | 14.46 | 13.29 | 7.79 | -17.33 | 0.01 | -2.18 |
Net Cash Flow | 60.17 | -63.88 | -79.23 | 265.39 | -13.25 | -176.03 |
Free Cash Flow | 734.22 | 766.31 | 529.07 | 740.9 | 489.99 | -9.74 |
Free Cash Flow Growth | 12.97% | 44.84% | -28.59% | 51.21% | - | - |
Free Cash Flow Margin | 36.05% | 37.82% | 29.10% | 43.87% | 35.00% | -0.94% |
Free Cash Flow Per Share | 13.49 | 14.05 | 9.70 | 13.59 | 8.98 | -0.18 |
Cash Interest Paid | 4.88 | 4.88 | 5.95 | 2.94 | 1.35 | 2.81 |
Cash Income Tax Paid | 284.39 | 284.39 | 289.64 | 259.68 | 199.74 | 92.59 |
Levered Free Cash Flow | 608.3 | 663.18 | 400.4 | 612.07 | 412.52 | 7.73 |
Unlevered Free Cash Flow | 611.09 | 666.12 | 404.12 | 613.91 | 413.36 | 9.48 |
Change in Working Capital | -5.69 | -18.28 | -196.49 | 131.93 | 10.91 | -78.8 |